Elanco Animal Net Worth
Elanco Animal Net Worth Breakdown | ELAN |
Elanco Animal Net Worth Analysis
Elanco Animal's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Elanco Animal's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Elanco Animal's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Elanco Animal's net worth analysis. One common approach is to calculate Elanco Animal's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Elanco Animal's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Elanco Animal's net worth. This approach calculates the present value of Elanco Animal's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Elanco Animal's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Elanco Animal's net worth. This involves comparing Elanco Animal's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Elanco Animal's net worth relative to its peers.
To determine if Elanco Animal is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Elanco Animal's net worth research are outlined below:
Elanco Animal Health generated a negative expected return over the last 90 days | |
Elanco Animal Health is unlikely to experience financial distress in the next 2 years | |
Over 99.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from finance.yahoo.com: Elanco Animal Health Among the Most Undervalued Biotech Stocks to Invest In |
Elanco Animal Quarterly Good Will |
|
Elanco Animal uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Elanco Animal Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Elanco Animal's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
20th of February 2024 Upcoming Quarterly Report | View | |
14th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
20th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Elanco Animal Target Price Consensus
Elanco target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Elanco Animal's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
16 | Buy |
Most Elanco analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Elanco stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Elanco Animal Health, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationElanco Animal Target Price Projection
Elanco Animal's current and average target prices are 10.53 and 17.33, respectively. The current price of Elanco Animal is the price at which Elanco Animal Health is currently trading. On the other hand, Elanco Animal's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Elanco Animal Market Quote on 22nd of March 2025
Target Price
Analyst Consensus On Elanco Animal Target Price
Know Elanco Animal's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Elanco Animal is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Elanco Animal Health backward and forwards among themselves. Elanco Animal's institutional investor refers to the entity that pools money to purchase Elanco Animal's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | State Street Corp | 2024-12-31 | 10.4 M | Geode Capital Management, Llc | 2024-12-31 | 8.2 M | Jpmorgan Chase & Co | 2024-12-31 | 7.5 M | Manufacturers Life Insurance Co | 2024-12-31 | 6.9 M | Brandes Investment Partners & Co | 2024-12-31 | 5.7 M | Charles Schwab Investment Management Inc | 2024-12-31 | 4.7 M | Prudential Financial Inc | 2024-12-31 | 4.2 M | Ubs Group Ag | 2024-12-31 | 4.2 M | Canada Pension Plan Investment Board | 2024-12-31 | 4 M | Dodge & Cox | 2024-12-31 | 83.2 M | Primecap Management Company | 2024-12-31 | 51.2 M |
Follow Elanco Animal's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.23 B.Market Cap |
|
Project Elanco Animal's profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.07 | 0.08 | |
Return On Capital Employed | 0.02 | 0.03 | |
Return On Assets | 0.03 | 0.03 | |
Return On Equity | 0.06 | 0.06 |
When accessing Elanco Animal's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Elanco Animal's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Elanco Animal's profitability and make more informed investment decisions.
Evaluate Elanco Animal's management efficiency
Elanco Animal Health has return on total asset (ROA) of 0.0119 % which means that it generated a profit of $0.0119 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0549 %, meaning that it created $0.0549 on every $100 dollars invested by stockholders. Elanco Animal's management efficiency ratios could be used to measure how well Elanco Animal manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of March 2025, Return On Tangible Assets is likely to grow to 0.08. Also, Return On Capital Employed is likely to grow to 0.03. At this time, Elanco Animal's Total Assets are very stable compared to the past year. As of the 22nd of March 2025, Non Current Assets Total is likely to grow to about 10.5 B, though Net Tangible Assets are likely to grow to (3 B).Last Reported | Projected for Next Year | ||
Book Value Per Share | 12.34 | 18.06 | |
Tangible Book Value Per Share | (4.05) | (4.25) | |
Enterprise Value Over EBITDA | 7.10 | 7.46 | |
Price Book Value Ratio | 0.98 | 1.68 | |
Enterprise Value Multiple | 7.10 | 7.46 | |
Price Fair Value | 0.98 | 1.68 |
Evaluating the management effectiveness of Elanco Animal allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Elanco Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Enterprise Value Revenue 2.0747 | Revenue | Quarterly Revenue Growth (0.01) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Elanco Animal insiders, such as employees or executives, is commonly permitted as long as it does not rely on Elanco Animal's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Elanco Animal insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Elanco Animal Corporate Filings
8K | 17th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 11th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
7th of March 2025 Other Reports | ViewVerify | |
12th of February 2025 Other Reports | ViewVerify |
Elanco Animal Earnings Estimation Breakdown
The calculation of Elanco Animal's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Elanco Animal is estimated to be 0.3118 with the future projection ranging from a low of 0.29 to a high of 0.3204. Please be aware that this consensus of annual earnings estimates for Elanco Animal Health is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.29 Lowest | Expected EPS | 0.32 Highest |
Elanco Animal Earnings Projection Consensus
Suppose the current estimates of Elanco Animal's value are higher than the current market price of the Elanco Animal stock. In this case, investors may conclude that Elanco Animal is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Elanco Animal's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
16 | 78.63% | 0.14 | 0.3118 | 0.68 |
Elanco Animal Earnings History
Earnings estimate consensus by Elanco Animal Health analysts from Wall Street is used by the market to judge Elanco Animal's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Elanco Animal's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Elanco Animal Quarterly Gross Profit |
|
Elanco Animal Earnings per Share Projection vs Actual
Actual Earning per Share of Elanco Animal refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Elanco Animal Health predict the company's earnings will be in the future. The higher the earnings per share of Elanco Animal, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Elanco Animal Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Elanco Animal, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Elanco Animal should always be considered in relation to other companies to make a more educated investment decision.Elanco Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Elanco Animal's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2025-02-24 | 2024-12-31 | 0.1486 | 0.14 | -0.0086 | 5 | ||
2024-11-07 | 2024-09-30 | 0.12 | 0.13 | 0.01 | 8 | ||
2024-08-08 | 2024-06-30 | 0.24 | 0.3 | 0.06 | 25 | ||
2024-05-08 | 2024-03-31 | 0.26 | 0.34 | 0.08 | 30 | ||
2024-02-26 | 2023-12-31 | 0.11 | 0.08 | -0.03 | 27 | ||
2023-11-07 | 2023-09-30 | 0.12 | 0.18 | 0.06 | 50 | ||
2023-08-07 | 2023-06-30 | 0.05 | 0.18 | 0.13 | 260 | ||
2023-05-09 | 2023-03-31 | 0.29 | 0.45 | 0.16 | 55 | ||
2023-02-21 | 2022-12-31 | 0.13 | 0.19 | 0.06 | 46 | ||
2022-11-08 | 2022-09-30 | 0.16 | 0.2 | 0.04 | 25 | ||
2022-08-08 | 2022-06-30 | 0.25 | 0.36 | 0.11 | 44 | ||
2022-05-09 | 2022-03-31 | 0.35 | 0.36 | 0.01 | 2 | ||
2022-02-24 | 2021-12-31 | 0.17 | 0.21 | 0.04 | 23 | ||
2021-11-05 | 2021-09-30 | 0.17 | 0.19 | 0.02 | 11 | ||
2021-08-09 | 2021-06-30 | 0.26 | 0.28 | 0.02 | 7 | ||
2021-05-07 | 2021-03-31 | 0.23 | 0.37 | 0.14 | 60 | ||
2021-02-24 | 2020-12-31 | 0.09 | 0.12 | 0.03 | 33 | ||
2020-11-06 | 2020-09-30 | 0.12 | 0.13 | 0.01 | 8 | ||
2020-07-30 | 2020-06-30 | 0.06 | 0.09 | 0.03 | 50 | ||
2020-05-07 | 2020-03-31 | 0.24 | 0.13 | -0.11 | 45 | ||
2020-02-19 | 2019-12-31 | 0.23 | 0.23 | 0.0 | 0 | ||
2019-11-06 | 2019-09-30 | 0.26 | 0.3 | 0.04 | 15 | ||
2019-08-13 | 2019-06-30 | 0.26 | 0.28 | 0.02 | 7 | ||
2019-05-09 | 2019-03-31 | 0.23 | 0.25 | 0.02 | 8 | ||
2019-02-06 | 2018-12-31 | 0.28 | 0.29 | 0.01 | 3 | ||
2018-11-06 | 2018-09-30 | 0.25 | 0.29 | 0.04 | 16 | ||
2018-09-21 | 2018-06-30 | 0 | -0.97 | -0.97 | 0 |
Elanco Animal Corporate Directors
Joshua Smiley | Independent Director | Profile | |
Carl McMillian | Independent Director | Profile | |
Denise ScotsKnight | Independent Director | Profile | |
Kirk McDonald | Independent Director | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elanco Animal. If investors know Elanco will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elanco Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.71) | Earnings Share 0.68 | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets |
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elanco Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elanco Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elanco Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.